Second Amendment to Lease Agreement between Bulfinch Square Limited Partnership and Leap Therapeutics, Inc.
This amendment to the lease agreement between Bulfinch Square Limited Partnership (landlord) and Leap Therapeutics, Inc. (tenant) extends the original lease term for office space at 47 Thorndike Street, Cambridge, Massachusetts, until January 31, 2023. It allows the tenant until May 31, 2022, to notify the landlord if they wish to extend the lease further. The annual rent for the extended period is set at $444,686. The tenant confirms no brokers were involved and agrees to indemnify the landlord against any related claims. All other lease terms remain unchanged.
Exhibit 10.27
SECOND AMENDMENT TO LEASE
This is a Second Amendment to Lease dated as of October 1, 2021 by and between Bulfinch Square Limited Partnership, a Massachusetts limited partnership ("Landlord") and Leap Therapeutics, Inc., a Delaware corporation ("Tenant").
WHEREAS, Landlord and Tenant entered into a Lease dated November 13, 2018, as amended by First Amendment to Lease dated August 17, 2021 (as so amended, the "Lease") with respect to certain premises at 47 Thorndike Street, Cambridge, Massachusetts; and
WHEREAS, Tenant wishes to delay until May 31 , 2022 the date by which it can give an Election Notice to extend the term of the Lease for the Extended Term; and
WHEREAS, Landlord is willing to agree to such a delay in return for an extension of the Original Tenn until January 31, 2023.
NOW, THEREFORE, in consideration of the foregoing, Landlord and Tenant agree as follows:
IN WITNESS WHEREOF, Landlord and Tenant have executed this First Amendment to Lease as of the date first set forth above.
LANDLORD: | |||
| |||
Bulfinch Square Limited Partnership | |||
| |||
By: | Courthouse Associates, Inc., its general partner | ||
Kenneth Krozy | |||
Vice President |
TENANT: | ||
| ||
Leap Therapeutics, Inc. | ||
| ||
BB By: | /s/ DOUGLAS E. ONSI | |
Nam . ouglas E. Onsi | ||
Title: President & CEO |